Corrigendum to 'Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease' EBioMedicine 47 (2019) 446-456.

Clicks: 293
ID: 86803
2020
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Reference Key
hickson2020corrigendumebiomedicine Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hickson, LaTonya J;Langhi Prata, Larissa G P;Bobart, Shane A;Evans, Tamara K;Giorgadze, Nino;Hashmi, Shahrukh K;Herrmann, Sandra M;Jensen, Michael D;Jia, Qingyi;Jordan, Kyra L;Kellogg, Todd A;Khosla, Sundeep;Koerber, Daniel M;Lagnado, Anthony B;Lawson, Donna K;LeBrasseur, Nathan K;Lerman, Lilach O;McDonald, Kathleen M;McKenzie, Travis J;Passos, João F;Pignolo, Robert J;Pirtskhalava, Tamar;Saadiq, Ishran M;Schaefer, Kalli K;Textor, Stephen C;Victorelli, Stella G;Volkman, Tammie L;Xue, Ailing;Wentworth, Mark A;Wissler Gerdes, Erin O;Allison, David B;Dickinson, Stephanie L;Ejima, Keisuke;Atkinson, Elizabeth J;Lenburg, Marc;Zhu, Yi;Tchkonia, Tamara;Kirkland, James L;
Journal ebiomedicine
Year 2020
DOI S2352-3964(19)30810-2
URL
Keywords
proliferation gastric cancer aurkb ccnd1 h3s10ph

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.